van Rooijen N - Search Results

1

CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

Majeti R, Chao MP, Alizadeh AA, Pang WW, Jaiswal S, Gibbs KD Jr, van Rooijen N, Weissman IL. Majeti R, et al. Among authors: van rooijen n. Cell. 2009 Jul 23;138(2):286-99. doi: 10.1016/j.cell.2009.05.045. Cell. 2009. PMID: 19632179 Free PMC article.

2

CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis.

Jaiswal S, Jamieson CH, Pang WW, Park CY, Chao MP, Majeti R, Traver D, van Rooijen N, Weissman IL. Jaiswal S, et al. Among authors: van rooijen n. Cell. 2009 Jul 23;138(2):271-85. doi: 10.1016/j.cell.2009.05.046. Cell. 2009. PMID: 19632178 Free PMC article.

3

Human CD47 expression permits survival of porcine cells in immunodeficient mice that express SIRPα capable of binding to human CD47.

Wang C, Wang H, Ide K, Wang Y, Van Rooijen N, Ohdan H, Yang YG. Wang C, et al. Among authors: van rooijen n. Cell Transplant. 2011;20(11-12):1915-20. doi: 10.3727/096368911X566253. Epub 2011 Apr 29. Cell Transplant. 2011. PMID: 21535911 Free PMC article.

4

Sensitizing protective tumor microenvironments to antibody-mediated therapy.

Pallasch CP, Leskov I, Braun CJ, Vorholt D, Drake A, Soto-Feliciano YM, Bent EH, Schwamb J, Iliopoulou B, Kutsch N, van Rooijen N, Frenzel LP, Wendtner CM, Heukamp L, Kreuzer KA, Hallek M, Chen J, Hemann MT. Pallasch CP, et al. Among authors: van rooijen n. Cell. 2014 Jan 30;156(3):590-602. doi: 10.1016/j.cell.2013.12.041. Cell. 2014. PMID: 24485462 Free PMC article.

5

Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts.

Theocharides AP, Jin L, Cheng PY, Prasolava TK, Malko AV, Ho JM, Poeppl AG, van Rooijen N, Minden MD, Danska JS, Dick JE, Wang JC. Theocharides AP, et al. Among authors: van rooijen n. J Exp Med. 2012 Sep 24;209(10):1883-99. doi: 10.1084/jem.20120502. Epub 2012 Sep 3. J Exp Med. 2012. PMID: 22945919 Free PMC article.

6

Targeting Macrophages Sensitizes Chronic Lymphocytic Leukemia to Apoptosis and Inhibits Disease Progression.

Galletti G, Scielzo C, Barbaglio F, Rodriguez TV, Riba M, Lazarevic D, Cittaro D, Simonetti G, Ranghetti P, Scarfò L, Ponzoni M, Rocchi M, Corti A, Anselmo A, van Rooijen N, Klein C, Ries CH, Ghia P, De Palma M, Caligaris-Cappio F, Bertilaccio MTS. Galletti G, et al. Among authors: van rooijen n. Cell Rep. 2016 Feb 23;14(7):1748-1760. doi: 10.1016/j.celrep.2016.01.042. Epub 2016 Feb 11. Cell Rep. 2016. PMID: 26876171 Free article.

7

Intratumoral but not systemic delivery of CpG oligodeoxynucleotide augments the efficacy of anti-CD20 monoclonal antibody therapy against B cell lymphoma.

Betting DJ, Yamada RE, Kafi K, Said J, van Rooijen N, Timmerman JM. Betting DJ, et al. Among authors: van rooijen n. J Immunother. 2009 Jul-Aug;32(6):622-31. doi: 10.1097/CJI.0b013e3181ab23f1. J Immunother. 2009. PMID: 19483647

8

5-azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia.

Sutherland MK, Yu C, Anderson M, Zeng W, van Rooijen N, Sievers EL, Grewal IS, Law CL. Sutherland MK, et al. Among authors: van rooijen n. MAbs. 2010 Jul-Aug;2(4):440-8. doi: 10.4161/mabs.12203. Epub 2010 Jul 1. MAbs. 2010. PMID: 20495353 Free PMC article.

9

Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action.

Wunderlich FT, Ströhle P, Könner AC, Gruber S, Tovar S, Brönneke HS, Juntti-Berggren L, Li LS, van Rooijen N, Libert C, Berggren PO, Brüning JC. Wunderlich FT, et al. Among authors: van rooijen n. Cell Metab. 2010 Sep 8;12(3):237-49. doi: 10.1016/j.cmet.2010.06.011. Cell Metab. 2010. PMID: 20816090 Free article.

10

Cancer-induced expansion and activation of CD11b+ Gr-1+ cells predispose mice to adenoviral-triggered anaphylactoid-type reactions.

Pande K, Ueda R, Machemer T, Sathe M, Tsai V, Brin E, Delano MJ, Van Rooijen N, McClanahan TK, Talmadge JE, Moldawer LL, Phillips JH, LaFace DM. Pande K, et al. Among authors: van rooijen n. Mol Ther. 2009 Mar;17(3):508-15. doi: 10.1038/mt.2008.280. Epub 2009 Jan 6. Mol Ther. 2009. PMID: 19127252 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

861 results

Search Page

Filters